tiprankstipranks
Top Stocks
Top Analyst StocksTop Smart Score StocksTop Insiders Stocks
Popular
Stock ScreenerTop Online Growth StocksTrending StocksPenny Stock Screener
Dividend Investing
Dividend CalculatorDividend Yield CalculatorDividend StocksDividend NewsDividend Calendar
ETFs
ETF CenterSPY ETFQQQ ETF
Stock Comparison
ChatGPT StocksValue StocksAirline StocksAI StocksOil StocksBank StocksFAANG StocksCompare More Stocks…
Calendars
IPO CalendarEarnings Calendar
Popular
Dividend CalendarEconomic Calendar
New
Market HolidaysDaily Analyst RatingsDaily Insider Trading
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Stock Market NewsStock Analysis & Ideas
Popular
ETF NewsGlobal Markets NewsExpert SpotlightTipRanks LabsEarnings Reports InsightsMarket BreakdownsDividend Stock NewsCrypto News
My PortfolioMy PerformanceMy Portfolio AnalysisCrowd InsightsMy Watchlist
About Us
About TipRanksContact Us
Working with TipRanks
Enterprise SolutionsBest Online BrokersBecome an Affiliate
Follow Us
NewsSmart PortfolioExpert Center
TOOLS
My Portfolio
My Watchlist
Earnings Calendar
Stock Screener
Penny Stocks
Top Stocks
ETF Center
STOCKS
BABA
AAPL
SPY
AMZN
QQQ
TSLA
NVDA
ADVANCED RESEARCH
TipRanks Premium
Invest Like a Pro with Unique Data & Simplifed ToolsTry Now
Smart Score Stocks
Analysts' Hot Stocks
Insiders' Hot Stocks
Popular
Trending Stocks
Fastest Growing Websites
Hot
Penny Stocks
Market Movers
My Experts
Top Firms
Top Wall Street Analysts
Top Financial Bloggers
Top Corporate Insiders
Popular
Top Hedge Fund Managers
Top Individual Investors
Stock Screener
Stock Comparison
Dividend Calculator
Popular
ETF Center
Dividend Yield Calculator
Daily Stock Ratings
Daily Insider Transactions
Stock ComparisonPOPULAR COMPARISONS
Dividend Stocks
ChatGPT Stocks
Airline Stocks
AI Stocks
My Portfolio
My Performance
My Portfolio Analysis
Crowd Insights
Earnings Calendar
Popular
Dividend Calendar
Economic Calendar
New
IPO Calendar
Stock Market Holidays
Market News
ETF News
Stock Analysis & Ideas
Popular
Global Markets News
Expert Spotlight
Tipranks Labs
Earnings Reports Insights
Market Breakdowns
Dividend Stock News
Crypto News
About TipRanks
For Business
Become an Affiliate
Reviews
Contact Us
Plans & Pricing

HGEN Stock Latest News

Humanigen reinstated with a Neutral at Cantor Fitzgerald
The FlyHumanigen reinstated with a Neutral at Cantor Fitzgerald
2M ago
HGEN
Humanigen Stock: Why It Crashed and Where It’s Headed
Stock Analysis & IdeasHumanigen Stock: Why It Crashed and Where It’s Headed
8M ago
HGEN
Humanigen: Topline Data for Covid-19 Treatment Expected in July; What This Could Mean for the Stock
Stock Analysis & IdeasHumanigen: Topline Data for Covid-19 Treatment Expected in July; What This Could Mean for the Stock
9M ago
HGEN
Humanigen: A ‘Transformative Year’ Awaits, Says Analyst
Stock Analysis & IdeasHumanigen: A ‘Transformative Year’ Awaits, Says Analyst
11M ago
HGEN
Insiders Buy These 2 Stocks at Discounted Prices — Analysts Say They Have Over 200% Upside Potential
Stock Analysis & IdeasInsiders Buy These 2 Stocks at Discounted Prices — Analysts Say They Have Over 200% Upside Potential
1y ago
HGEN
NOTV
Humanigen: New Publication Details Lenzilumab’s Economic Benefits, Says Analyst
Stock Analysis & IdeasHumanigen: New Publication Details Lenzilumab’s Economic Benefits, Says Analyst
1y ago
HGEN
Why 2022 Holds Hope for Humanigen Stock, According to This Analyst
Stock Analysis & IdeasWhy 2022 Holds Hope for Humanigen Stock, According to This Analyst
1y ago
HGEN
Humanigen: All You Need to Know Right Now
Stock Analysis & IdeasHumanigen: All You Need to Know Right Now
1y ago
HGEN
Is Humanigen Stock Due for a Turnaround? Analyst Weighs In
Stock Analysis & IdeasIs Humanigen Stock Due for a Turnaround? Analyst Weighs In
1y ago
HGEN
Humanigen Stock to $28? This Analyst Thinks So
Stock Analysis & IdeasHumanigen Stock to $28? This Analyst Thinks So
1y ago
HGEN
Humanigen: Lenzilumab Could Reach the UK Market in 1Q22, Says Analyst
Stock Analysis & IdeasHumanigen: Lenzilumab Could Reach the UK Market in 1Q22, Says Analyst
1y ago
HGEN
Has Humanigen Stock Hit Bottom? Oppenheimer Looks for the Silver Lining
Stock Analysis & IdeasHas Humanigen Stock Hit Bottom? Oppenheimer Looks for the Silver Lining
2y ago
HGEN
Humanigen: Lenz Could Become a $1.45 Billion Drug, if Approved, Says Analyst
Stock Analysis & IdeasHumanigen: Lenz Could Become a $1.45 Billion Drug, if Approved, Says Analyst
2y ago
HGEN